Related references
Note: Only part of the references are listed.Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma
Takafumi Handa et al.
HISTOPATHOLOGY (2023)
Standardizing analysis of intra-tumoral heterogeneity with computational pathology
Ameesha Paliwal et al.
GENES CHROMOSOMES & CANCER (2023)
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance
Soohyun Hwang et al.
MODERN PATHOLOGY (2023)
Killing SCLC: insights into how to target a shapeshifting tumor
Kate D. Sutherland et al.
GENES & DEVELOPMENT (2022)
Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers
Song Qu et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study
Zsolt Megyesfalvi et al.
JOURNAL OF PATHOLOGY (2022)
Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
Xiao-Long Ding et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC
Marina K. Baine et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay et al.
CANCER CELL (2021)
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment
Soohyun Hwang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
John T. Poirier et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
Abbie S. Ireland et al.
CANCER CELL (2020)
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K. Baine et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
Yu-Han Huang et al.
GENES & DEVELOPMENT (2018)
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
June-Koo Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes
Anna M. Varghese et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)